AstraZeneca drags Dr Reddy's Labs to court on patent, says report
Updated : July 25, 2018 12:55 PM IST
AstraZeneca filed a lawsuit in the Delhi High Court against the pharmaceutical major Dr Reddy’s Laboratories to block the company from launching the generic versions of Brilinta.
The court asked Dr Reddy’s on Tuesday to file a reply to the lawsuit and will hear its arguments on July 31.
One of AstraZeneca’s key patents for Brilinta expired in India this month, it has triggered the launch opportunities for local drug makers.